Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GUCY1B2 | O75343 | 7/20 | 0.42 |
| ▸ | GUCY1A2 | P33402 | 7/20 | 0.42 |
| ▸ | GUCY1A1 | Q02108 | 7/20 | 0.42 |
| ▸ | GUCY1B1 | Q02153 | 7/20 | 0.42 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.40 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.40 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | KDM1A | O60341 | 2/20 | 0.35 |
| ▸ | EGFR | P00533 | 2/20 | 0.35 |
| ▸ | SRC | P12931 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | S1PR5 | Q9H228 | 1/20 | 0.33 |
| ▸ | MRGPRX4 | Q96LA9 | 1/20 | 0.33 |
| ▸ | PTGER1 | P34995 | 1/20 | 0.33 |
| ▸ | HTR1A | P08908 | 1/20 | 0.33 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.33 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7797048 | 0.75 | HDAC4 (0.39) | HDAC4HDAC7HDAC5MEN1MAPT | |
| SCHEMBL7796571 | 0.73 | HDAC4 (0.46) | HDAC4HDAC7HDAC5MEN1MAPT | |
| SCHEMBL8741715 | 0.72 | HDAC4 (0.47) | HDAC4HDAC7HDAC5MEN1MAPT | |
| SCHEMBL27488661 | 0.72 | HDAC4 (0.40) | HDAC4HDAC7HDAC5MEN1MAPT | |
| SCHEMBL31613807 | 0.71 | HDAC4 (0.66) | HDAC4HDAC7HDAC5MEN1MAPT | |
| SCHEMBL2989515 | 0.71 | HDAC4 (0.66) | HDAC4HDAC7HDAC5MEN1MAPT | |
| SCHEMBL2218310 | 0.70 | HDAC4 (0.50) | HDAC4HDAC7HDAC5MEN1MAPT | |
| SCHEMBL3855305 | 0.70 | HDAC4 (0.42) | HDAC4HDAC7HDAC5MEN1MAPT | |
| SCHEMBL27864842 | 0.70 | MEN1 (0.42) | HDAC4HDAC7HDAC5MEN1MAPT | |
| SCHEMBL4195312 | 0.70 | HDAC4 (0.37) | HDAC4HDAC7HDAC5MEN1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170210825-A1 | MONOSPECIFIC AND MULTISPECIFIC ANTIBODIES AND METHOD OF USE | BAYER IP GMBH (US) | 2017-07-27 | — | — | US | disclosed |
| US-9624309-B2 | Monospecific and multispecific antibodies and method of use | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2017-04-18 | — | — | US | disclosed |
| EP-2532676-B1 | Protease-regulated antibody | Bayer Pharma AG (DE) | 2017-03-22 | — | — | EP | disclosed |
| EP-1963372-B1 | ANTI-MN ANTIBODIES AND METHODS OF USING THE SAME | BAYER HEALTHCARE LLC (US) | 2013-07-03 | — | — | EP | disclosed |
| EP-2532676-A1 | Protease-regulated antibody | Bayer Pharma Aktiengesellschaft (DE) | 2012-12-12 | — | — | EP | disclosed |
| US-20120301468-A1 | ANTI-MN ANTIBODIES AND METHODS OF USING SAME | BAYER HEALTHCARE LLC (US) | 2012-11-29 | — | — | US | disclosed |
| EP-2476706-A2 | Anti-MN antibodies and methods of using same | Bayer HealthCare LLC (US) | 2012-07-18 | — | — | EP | disclosed |
| US-8168758-B2 | Anti-MN antibodies and methods of using same | BAYER HEALTHCARE LLC (US) | 2012-05-01 | — | — | US | disclosed |
| US-20110229476-A1 | MONOSPECIFIC AND MULTISPECIFIC ANTIBODIES AND METHOD OF USE | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2011-09-22 | — | — | US | disclosed |
| EP-1913391-B1 | QUANTITATIVE ASSAYS FOR PDGFR-beta IN BODY FLUIDS | SIEMENS HEALTHCARE DIAGNOSTICS (US) | 2010-12-29 | — | — | EP | disclosed |
| WO-2009021754-A2 | MONOSPECIFIC AND MULTISPECIFIC ANTIBODIES AND METHOD OF USE | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2009-02-19 | — | — | WO | disclosed |
| US-20080311604-A1 | Methods for Prediction and Prognosis of Cancer, and Monitoring Cancer Therapy | BAYER HEALTHCARE LLC | 2008-12-18 | — | — | US | disclosed |
| US-20080311601-A1 | Methods for Prediction and Prognosis of Cancer, and Monitoring Cancer Therapy | BAYER HEALTHCARE LLC | 2008-12-18 | — | — | US | disclosed |
| EP-1946116-A2 | METHODS FOR PREDICTION AND PROGNOSIS OF CANCER, AND MONITORING CANCER THERAPY | Bayer Healthcare, LLC (US) | 2008-07-23 | — | — | EP | disclosed |
| EP-1946115-A2 | METHODS FOR PREDICTION AND PROGNOSIS OF CANCER, AND MONITORING CANCER THERAPY | Bayer Healthcare, LLC (US) | 2008-07-23 | — | — | EP | disclosed |
| EP-1943521-A2 | METHODS FOR PREDICTION AND PROGNOSIS OF CANCER, AND MONITORING CANCER THERAPY | Bayer HealthCare LLC (US) | 2008-07-16 | — | — | EP | disclosed |
| WO-2007056012-A2 | METHODS FOR PREDICTION AND PROGNOSIS OF CANCER, AND MONITORING CANCER THERAPY | BAYER HEALTHCARE LLC (US) | 2007-05-18 | — | — | WO | disclosed |
| WO-2007056011-A2 | METHODS FOR PREDICTION AND PROGNOSIS OF CANCER, AND MONITORING CANCER THERAPY | BAYER HEALTHCARE LLC (US) | 2007-05-18 | — | — | WO | disclosed |
| WO-2007047955-A2 | METHODS FOR PREDICTION AND PROGNOSIS OF CANCER, AND MONITORING CANCER THERAPY | BAYER HEALTHCARE LLC (US) | 2007-04-26 | — | — | WO | disclosed |
| US-20070037224-A1 | Quantitative assays for PDGFR-beta in body fluids | HAMER PETER J | 2007-02-15 | — | — | US | disclosed |